{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:03:32Z","timestamp":1777442612627,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000003133","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T13:04:32Z","timestamp":1461330272000},"page":"e3133","source":"Crossref","is-referenced-by-count":10,"title":["Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"95","author":[{"given":"Kuo-Hsin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Tzu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Hung","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Feng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Hsi","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-75-20210226","first-page":"333","article-title":"Etiology, diagnosis and treatment of infectious esophagitis","volume":"8","author":"Rosolowski","year":"2013","journal-title":"Prz Gastroenterol"},{"key":"R2-75-20210226","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-012-2520-x","article-title":"Acid suppression therapy as a risk factor for Candida esophagitis","volume":"58","author":"Kim","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R3-75-20210226","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s100960050437","article-title":"Risk factors for esophageal candidiasis","volume":"19","author":"Chocarro Martinez","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R4-75-20210226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1442-2050.2003.00305.x","article-title":"Clinical findings and risk factors for Candida esophagitis in outpatients","volume":"16","author":"Underwood","year":"2003","journal-title":"Dis Esophagus"},{"key":"R5-75-20210226","first-page":"511","article-title":"The Ras-Raf-MEK-ERK pathway in the treatment of cancer","volume":"25","author":"Hilger","year":"2002","journal-title":"Onkologie"},{"key":"R6-75-20210226","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2174\/1381612023393026","article-title":"BAY 43-9006: preclinical data","volume":"8","author":"Wilhelm","year":"2002","journal-title":"Curr Pharm Des"},{"key":"R7-75-20210226","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-75-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"R9-75-20210226","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/leu.2008.58","article-title":"Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation","volume":"22","author":"Zhao","year":"2008","journal-title":"Leukemia"},{"key":"R10-75-20210226","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/09553002.2013.791405","article-title":"Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK\/ERK signal pathway","volume":"89","author":"Dai","year":"2013","journal-title":"Int J Radiat Biol"},{"key":"R11-75-20210226","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/1471-2407-12-485","article-title":"Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"R12-75-20210226","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation; radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br J Radiol"},{"key":"R13-75-20210226","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: a clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett"},{"key":"R14-75-20210226","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.3748\/wjg.14.7075","article-title":"Acute and persisting Th2-like immune response after fractionated colorectal gamma-irradiation","volume":"14","author":"Gremy","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R15-75-20210226","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/09553002.2015.1068461","article-title":"Analysis of immune cell populations and cytokine profiles in murine splenocytes exposed to whole-body low-dose irradiation","volume":"91","author":"Song","year":"2015","journal-title":"Int J Radiat Biol"},{"key":"R16-75-20210226","first-page":"375","article-title":"Pelvic irradiation modulates the pharmacokinetics of cisplatin in the plasma and lymphatic system","volume":"7","author":"Tsai","year":"2015","journal-title":"Am J Transl Res"},{"key":"R17-75-20210226","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0016-5085(76)80347-2","article-title":"Candida esophagitis: a prospective study of 27 cases","volume":"71","author":"Kodsi","year":"1976","journal-title":"Gastroenterology"},{"key":"R18-75-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/0044011-200929010-00007","article-title":"Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma","volume":"29","author":"Hsieh","year":"2009","journal-title":"Clin Drug Investig"},{"key":"R19-75-20210226","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2147\/OTT.S64706","article-title":"Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy","volume":"7","author":"Hsieh","year":"2014","journal-title":"Onco Targets Ther"},{"key":"R20-75-20210226","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ijrobp.2014.01.017","article-title":"Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma","volume":"88","author":"Chen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-75-20210226","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/BF02208680","article-title":"Conventional dose of omeprazole alters gastric flora","volume":"40","author":"Karmeli","year":"1995","journal-title":"Dig Dis Sci"},{"key":"R22-75-20210226","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000658-197406000-00007","article-title":"Bacteriology of the stomach immediately following vagotomy: the growth of Candida albicans","volume":"179","author":"Brooks","year":"1974","journal-title":"Ann Surg"},{"key":"R23-75-20210226","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02779203","article-title":"Esophageal candidiasis","volume":"23","author":"Naito","year":"1988","journal-title":"Gastroenterol Jpn"},{"key":"R24-75-20210226","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1182\/blood-2007-02-075945","article-title":"Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses","volume":"111","author":"Hipp","year":"2008","journal-title":"Blood"},{"key":"R25-75-20210226","first-page":"181","article-title":"Enhancement of macrophage candidacidal activity by interferon-gamma","volume":"4","author":"Marodi","year":"1993","journal-title":"Immunodeficiency"},{"key":"R26-75-20210226","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.4049\/jimmunol.153.12.5643","article-title":"Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants","volume":"153","author":"Marodi","year":"1994","journal-title":"J Immunol"},{"key":"R27-75-20210226","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"key":"R28-75-20210226","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/sj.onc.1209706","article-title":"Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K\/Akt\/NF-kappaB signal transduction pathway","volume":"25","author":"Cheng","year":"2006","journal-title":"Oncogene"},{"key":"R29-75-20210226","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1748-717X-5-12","article-title":"Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy\/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I\/II study","volume":"5","author":"Zhao","year":"2010","journal-title":"Radiat Oncol"},{"key":"R30-75-20210226","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0016-5085(94)90613-0","article-title":"Esophageal infections: risk factors, presentation, diagnosis, and treatment","volume":"106","author":"Baehr","year":"1994","journal-title":"Gastroenterology"},{"key":"R31-75-20210226","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/516315","article-title":"Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues","volume":"26","author":"Darouiche","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:00:56Z","timestamp":1692298856000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603150-00075"}},"subtitle":["Case Report"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003133","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}